PCSM-02 SURVIVORSHIP CARE PLANNING IN THE NEURO-ONCOLOGY CLINIC

Por Amidei, Christina, Arzbaecher, Jean, Nicholas, M. Kelly
Publicado no Neuro Oncol (2015)

Targeted therapy in the treatment of malignant gliomas

Por Lukas, Rimas V, Boire, Adrienne, Nicholas, M Kelly
Publicado em 2009

Id4 and FABP7 are preferentially expressed in cells with astrocytic features in oligodendrogliomas and oligoastrocytomas

Por Liang, Yu, Bollen, Andrew W, Nicholas, M Kelly, Gupta, Nalin
Publicado em 2005

PCSM-01 INTEGRATING PATIENT SELF-REPORT DATA INTO THE NEURO-ONCOLOGY CLINIC EXPERIENCE: LESSONS LEARNED

Por Amidei, Christina, Frazier-Warmack, Victoria, Arzbaecher, Jean, Nicholas, M. Kelly
Publicado no Neuro Oncol (2015)

EG-08 IDH MUTATIONS IN GLIOMAS ASSOCIATED WITH ENCHONDROMATOSIS

Por Nicholas, M. Kelly, Joseph, Loren, Venneti, Sriram, Daher, Ahmad, Pytel, Peter
Publicado em 2014

A Phase I Study of Continuous Infusion Cilengitide in Patients with Solid Tumors

Por O’Donnell, Peter H., Undevia, Samir D., Stadler, Walter M., Karrison, Theodore M., Nicholas, M. Kelly, Janisch, Linda, Ratain, Mark J.
Publicado em 2010

Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme

Por Liang, Yu, Diehn, Maximilian, Watson, Nathan, Bollen, Andrew W., Aldape, Ken D., Nicholas, M. Kelly, Lamborn, Kathleen R., Berger, Mitchel S., Botstein, David, Brown, Patrick O., Israel, Mark A.
Publicado em 2005

Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme

Por Larson, David A., Suplica, Jeffrey M., Chang, Susan M., Lamborn, Kathleen R., McDermott, Michael W., Sneed, Penny K., Prados, Michael D., Wara, William M., Nicholas, M. Kelly, Berger, Mitchel S.
Publicado em 2004

The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy

Por Zhai, Lijie, Dey, Mahua, Lauing, Kristen L., Gritsina, Galina, Kaur, Rajwant, Lukas, Rimas V., Nicholas, M. Kelly, Rademaker, Alfred W., Dostal, Carlos R., McCusker, Robert H., Raizer, Jeffrey J., Parsa, Andrew T., Bloch, Orin, Wainwright, Derek A.
Publicado no J Clin Neurosci (2015)

Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study

Por Prados, Michael D., Yung, W.K. Alfred, Fine, Howard A., Greenberg, Harry S., Junck, Larry, Chang, Susan M., Nicholas, M. Kelly, Robins, H. Ian, Mehta, Minesh P., Fink, Karen L., Jaeckle, Kurt A., Kuhn, John, Hess, Kenneth R., Schold, S. Clifford
Publicado em 2004

A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study

Por Prados, Michael D., Lamborn, Kathleen, Yung, W.K.A., Jaeckle, Kurt, Robins, H. Ian, Mehta, Minesh, Fine, Howard A., Wen, Patrick Y., Cloughesy, Timothy, Chang, Susan, Nicholas, M. Kelly, Schiff, David, Greenberg, Harry, Junck, Larry, Fink, Karen, Hess, Ken, Kuhn, John
Publicado em 2006

Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study

Por Prados, Michael D., Yung, W.K.A., Jaeckle, Kurt A., Robins, H. Ian, Mehta, Minesh P., Fine, Howard A., Wen, Patrick Y., Cloughesy, Timothy F., Chang, Susan M., Nicholas, M. Kelly, Schiff, David, Greenberg, Harry S., Junck, Larry, Fink, Karen L., Hess, Kenneth R., Kuhn, John
Publicado em 2004

Phase II Study of Fenretinide (NSC 374551) in Adults With Recurrent Malignant Gliomas: A North American Brain Tumor Consortium Study

Por Puduvalli, Vinay K., Yung, W.K. Alfred, Hess, Kenneth R., Kuhn, John G., Groves, Morris D., Levin, Victor A., Zwiebel, James, Chang, Susan M., Cloughesy, Timothy F., Junck, Larry, Wen, Patrick, Lieberman, Frank, Conrad, Charles A., Gilbert, Mark R., Meyers, Christina A., Liu, Vivien, Mehta, Minesh P., Nicholas, M. Kelly, Prados, Michael
Publicado em 2004